Wegovy And Zepbound Doses Available Again After Months Of Shortages, FDA Says—But Supplies Are Still Limited

Forbes August 7, 2024
Robert Hart

Topline

More doses of Novo Nordisk’s popular weight loss drug Wegovy are back in stock in the U.S. after years of shortages and just days after all doses of Eli Lilly’s rival injection Zepbound became available, according to an update on the Food and Drug Administration’s website, though shortages are set to continue as pharma struggles to ramp up production..

Key Facts

What’s Driving The Shortage Of Glp-1 Weight Loss And Diabetes Drugs Like Ozempic?

Novo’s semaglutide and Lilly’s tirzepatide are at the forefront of a promising and growing class of drugs called GLP-1 agonists, which can help control hunger and blood sugar by mimicking the action of gut hormones. While GLP-1s have become famous for their ability to shed...

Today's Sponsors

Today's Sponsor